Hydrocortisone controlled release formulation
The disclosure relates to a pharmaceutical formulation comprising hydrocortisone and its use in the treatment of conditions that would benefit from a delayed release of hydrocortisone, in particular conditions such as adrenal insufficiency, inflammatory conditions and depression.
Saved in:
| Main Authors | , , |
|---|---|
| Format | Patent |
| Language | English |
| Published |
05.09.2017
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The disclosure relates to a pharmaceutical formulation comprising hydrocortisone and its use in the treatment of conditions that would benefit from a delayed release of hydrocortisone, in particular conditions such as adrenal insufficiency, inflammatory conditions and depression. |
|---|---|
| AbstractList | The disclosure relates to a pharmaceutical formulation comprising hydrocortisone and its use in the treatment of conditions that would benefit from a delayed release of hydrocortisone, in particular conditions such as adrenal insufficiency, inflammatory conditions and depression. |
| Author | Ross Richard Whitaker Martin Huatan Hiep |
| Author_xml | – fullname: Ross Richard – fullname: Whitaker Martin – fullname: Huatan Hiep |
| BookMark | eNrjYmDJy89L5WTQ9ahMKcpPzi8qySwGCigk5-eVFOXn5KSmKBSl5qQmFqcqpOUX5ZbmJJZk5ufxMLCmJeYUp_JCaW4GBTfXEGcP3dSC_PjU4oLE5NS81JL40GBLc1MDcwMTJyNjIpQAANHaLKc |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| ExternalDocumentID | US9750704B2 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_US9750704B23 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 12:45:31 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_US9750704B23 |
| Notes | Application Number: US201314374179 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170905&DB=EPODOC&CC=US&NR=9750704B2 |
| ParticipantIDs | epo_espacenet_US9750704B2 |
| PublicationCentury | 2000 |
| PublicationDate | 20170905 |
| PublicationDateYYYYMMDD | 2017-09-05 |
| PublicationDate_xml | – month: 09 year: 2017 text: 20170905 day: 05 |
| PublicationDecade | 2010 |
| PublicationYear | 2017 |
| RelatedCompanies | Diurnal Limited |
| RelatedCompanies_xml | – name: Diurnal Limited |
| Score | 3.1112301 |
| Snippet | The disclosure relates to a pharmaceutical formulation comprising hydrocortisone and its use in the treatment of conditions that would benefit from a delayed... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| Title | Hydrocortisone controlled release formulation |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170905&DB=EPODOC&locale=&CC=US&NR=9750704B2 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8QwEB6WVdSbrorrix6kt2DbpA8PReiLIuwDdyt7W_pIYGFpF7ci_nsnobt60VtIYJIMmcw3yTwAHvBc2EK4lHCzEIRZBSU5on7iWhQNIuE4vJABzqOxk2bsZWEverDaxcKoPKGfKjkiSlSJ8t6q-3rz84gVKd_K7WOxwq7mOZn7kd5Zx6ZrPBm2HgV-PJ1Ek1APQz-b6eNXNJYQ-BgswNv6QKJomWY_fgtkUMrmt0ZJTuFwisTq9gx6vB7AcbgrvDaAo1H3343NTvS250DSrwqVTSOrJzc11zof8zWvNFn3BJWRJvFnV43rArQknocpwXmX-z0us9l-hfQS-mj68yvQGK1yUTFW5o7FvKr0qFki_nJkGi4ELt4Qhn-Suf5n7AZOJLOUr5R9C_32_YPfoXJti3vFlm9CQX7D |
| link.rule.ids | 230,309,786,891,25594,76903 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1JS8NAFH6UKtabVsW65iC5BbNMFg9BSNIQtUmLTaS3kGUChZIUGxH_vW-GtHrR2zADszFv3vfNvAXgDs-FXlWmJlElrySi5pqUIeqXTFVDQlQZBs2Zg3MYGUFCnhf6ogfLrS8MjxP6yYMjokQVKO8tv6_XP49YHret3NznS6xqHv3Y9sSOHSum_CDroufY49nUm7qi69rJXIxekSwh8JGJg7f1nomMkDOlN4c5pax_axT_CPZn2FndHkOP1kMYuNvEa0M4CLv_bix2orc5ASn4KlHZNCx7clNTobMxX9FSYHlPUBkJDH922bhOQfDHsRtIOG66W2OazHcz1M6gj9SfnoNAtDKrSkKKzFCJVRaWphSIvwwWhguBizWC0Z_dXPzTdguDIA4n6eQpermEQ7Zx3G5Kv4J--_5Br1HRtvkN36JvVDuBrQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Hydrocortisone+controlled+release+formulation&rft.inventor=Ross+Richard&rft.inventor=Whitaker+Martin&rft.inventor=Huatan+Hiep&rft.date=2017-09-05&rft.externalDBID=B2&rft.externalDocID=US9750704B2 |